TELCON RF PHARMACEUTICAL. Inc. (KOSDAQ:A200230) acquired an additional 3.73% stake in Abion Inc. (XKON:A203400) from Leeds Investments Inc. and an individual for KRW 2.8 billion on July 1, 2020. As per terms, TELCON RF PHARMACEUTICAL. Inc. acquired 0.52 million shares at KRW 5,500 per share and increased its stake from 9.9% to 13.6%.

TELCON RF PHARMACEUTICAL. Inc. (KOSDAQ:A200230) completed the acquisition of an additional 3.73% stake in Abion Inc. (XKON:A203400) from Leeds Investments Inc. and an individual on July 1, 2020.